OICR News / Tag

ACTION

TAG ARCHIVE

Browse news tagged ACTION.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

TechnologyTreatment

Potential new approach to T-cell therapy shows early promise in the lab

Drs. Yonghong Wan and Scott Walsh McMaster University researchers validate a new treatment approach that could help bring the benefits of Adoptive T-cell therapies to patients with solid tumours Adoptive T-cell therapy (ACT) is an…

ArticleNov 18, 2019

TechnologyTreatment

Researchers find common cell process key to therapy resistance

Ottawa researchers discover a new way to make cancer cells more susceptible to virus-based therapies Over the past decade, researchers have made significant progress in designing oncolytic viruses (OVs) – viruses that destroy cancer cells…

ArticleAug 16, 2018

TechnologyTreatment

Combination of erectile dysfunction drugs and flu vaccine may help kill remaining cancer after surgery

A remarkable study led by Dr. Rebecca Auer from The Ottawa Hospital (TOH) shows that the unlikely combination of erectile dysfunction drugs and the flu vaccine may boost the immune system’s ability to clean up…

ArticleMay 17, 2018

TechnologyBreast cancer

Study shows virus-boosted immunotherapy can be effective against aggressive breast cancer

Researchers at The Ottawa Hospital and the University of Ottawa have found that a combination of two immunotherapies – oncolytic viruses and checkpoint inhibitors – was successful in treating triple-negative breast cancer in mouse models.…

ArticleJan 04, 2018

CollaborationTreatment

How OICR is helping to boost the body’s ability to fight cancer

The body’s immune system is incredibly powerful. Its ability to detect and destroy various pathogens makes it central to maintaining good health. While we all know the role it plays in fighting the common cold…

ArticleJul 11, 2017

CollaborationMultiple cancers

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer

Great strides have been made in cancer research, but much work remains to develop better treatments for the most lethal cancers and to advance new anti-cancer technologies. OICR is taking on a new approach, building…

ArticleMay 25, 2017

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

ACTION

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Potential new approach to T-cell therapy shows early promise in the lab

Researchers find common cell process key to therapy resistance

Combination of erectile dysfunction drugs and flu vaccine may help kill remaining cancer after surgery

Cancer solved together — in your inbox

Study shows virus-boosted immunotherapy can be effective against aggressive breast cancer

How OICR is helping to boost the body’s ability to fight cancer

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer